DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 157 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $415,875 | +22.9% | 42,393 | +33.3% | 0.01% | -18.8% |
| Q4 2022 | $338,448 | -13.2% | 31,809 | -14.8% | 0.02% | +23.1% |
| Q3 2022 | $390,000 | -23.5% | 37,322 | -6.5% | 0.01% | -13.3% |
| Q2 2022 | $510,000 | +22.3% | 39,906 | +5.3% | 0.02% | +87.5% |
| Q1 2022 | $417,000 | -19.2% | 37,893 | +4.5% | 0.01% | -20.0% |
| Q4 2021 | $516,000 | -36.6% | 36,260 | -13.4% | 0.01% | -33.3% |
| Q3 2021 | $814,000 | +143.7% | 41,879 | +23.9% | 0.02% | +200.0% |
| Q2 2021 | $334,000 | +3.4% | 33,799 | -2.6% | 0.01% | -16.7% |
| Q1 2021 | $323,000 | +23.8% | 34,697 | -34.9% | 0.01% | 0.0% |
| Q4 2020 | $261,000 | -3.3% | 53,266 | -13.2% | 0.01% | -33.3% |
| Q3 2020 | $270,000 | +5.5% | 61,372 | +103.6% | 0.01% | 0.0% |
| Q2 2020 | $256,000 | – | 30,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |